tirzepatide 2.5 mg/0.5ml MOUNJARO MG / 0.5 ML Zepbound Tirzepatide Injection 2.5 mg/0.5

Anxiety is not listed as an official side effect of tirzepatide in FDA approved prescribing information for either Mounjaro or Zepbound

At the time of implantation, the patient was receiving 12.5 mg per week and it was further increased to 15 mg per week after approximately 4 months for continued optimization of glucose control

Supportive Care and Monitoring Strategies Management includes: Intravenous fluids for rehydration Frequent blood glucose monitoring Administration of dextrose or glucagon if hypoglycemia is present Observation for delayed gastrointestinal symptoms or renal compromise Contacting Poison Control and Emergency Management In any suspected overdose scenario, prompt contact with local poison control centers and initiation of emergency medical care is imperative

Forgetting protein and resistance training

Compounded Formulas and Regulatory Standards Where available, TMates partners with licensed compounding pharmacies to provide access to cost-effective, high-quality formulations of GLP-1 medications